CareDx, Inc. - 8-K Filing
CareDx completed two transactions on June 30, 2026: selling its Lab Products business to Eurobio Scientific for $171.2 million in cash and acquiring Naveris Inc. for $161.8 million in cash plus up to an additional $100 million contingent on revenue milestones through 2027. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $CDNA